PRL02 Pearls: Medical Dermatology
DESCRIPTION
Medical pearls for dermatologists are actually shared experiences. Pearls and tips originate from experiences in clinic, in research, and even in relationships with patients, and the pearls of what not to do are often more salient than those of what to do. This session will bring a variety of pearls that will optimize patient outcomes and safety, while exploring the myths, misconceptions, and realities of comfort level of dermatologists for optimizing systemic therapies. The themes of “don’t be afraid” and the costs of not treating patients compared to costs to the system will be explored.
LEARNING OBJECTIVES
Apply the mechanisms of therapy to the mechanisms of disease to counter the process and not just the immediate presentation.
Develop opportunities for expanding treatment algorithms based on long-term safety and FDA approvals based on research data.
Compare and formulate the costs of not treating patients aggressively to the perceived costs to the system of therapies that are effective in dermatology.
SCHEDULE
3:15 PM
Introduction
3:15 PM
Introduction
Neal D. Bhatia, MD, FAAD
3:15 PM
Gut Check: High Yield GI–Derm Pearls
Ahuva Danielle Cices, MD, FAAD
3:25 PM
Old Habits Die Hard: Challenging the Status Quo of Lab Monitoring in Dermatology
Diego Dasilva, MD, FAAD
3:35 PM
DermPath and Hair Pearls
Michelle B. Tarbox, MD, FAAD
3:45 PM
Nailed It: Pearls for the Practicing Dermatologist
Shari Lipner, MD, PhD, FAAD
3:55 PM
Discussion
DIRECTOR
Neal D. Bhatia, MD, FAAD
Therapeutics Clinical Research, San Diego, California
SPEAKERS
Ahuva Danielle Cices, MD, FAAD
Diego Dasilva, MD, FAAD
Eastern Virginia Medical School
Shari Lipner, MD, PhD, FAAD
Michelle B. Tarbox, MD, FAAD
DISCLOSURES
Neal D. Bhatia, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria), Investigator(Grants/Research Funding); Alumis – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); Biofrontera AG – Consultant(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); Castle Biosciences – Consultant(Honoraria); Celldex – Investigator(Grants/Research Funding); Dermeleve – Consultant (1099 relationship)(Honoraria); Eli Lilly – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Consultant(Honoraria); Johnson and Johnson Consumer Products Company – Investigator(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Consultant(Honoraria); LEO Pharma, US – Investigator(Grants/Research Funding); Novartis – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Practical Dermatology – Other(Honoraria); Sagimet Biosciences – Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Soligenix, Inc – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); VeraDermics Inc. – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);
Ahuva Danielle Cices, MD, FAAD
AbbVie – Investigator(No Compensation Received); Almirall – Advisory Board(Honoraria), Other(Honoraria); Apogee Therapeutics – Advisory Board(Honoraria); Botanix Pharmaceuticals – Other(Honoraria); Bristol Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria), Investigator(No Compensation Received); Fre skincare – Consultant (1099 relationship)(Honoraria); Galderma – Other(Honoraria); Incyte – Other(Honoraria); Incyte Corporation – Investigator(No Compensation Received); Johnson & Johnson – Investigator(No Compensation Received); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria); Merck – Investigator(No Compensation Received); MoonLake Immunotherapeutics – Investigator(No Compensation Received); Novartis – Advisory Board(Honoraria), Investigator(No Compensation Received); Oruka Therapeutics – Advisory Board(Honoraria); Sanofi – Other(Honoraria); UCB – Advisory Board(Honoraria); Veradermics – Advisory Board(Honoraria);
Diego Dasilva, MD, FAAD
AbbVie – Speaker/Faculty Education(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Dermavant Sciences, Inc. – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Leo Pharma – Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria); UCB – Speaker(Honoraria); Verrica Pharmaceuticals Inc – Speaker(Honoraria);
Shari Lipner, MD, PhD, FAAD
Veradermics – Advisory Board(Honoraria);
Michelle B. Tarbox, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Dermaleve – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria); Sanofi/Regeneron – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);